Skip to main content

A Review of Evidence that the Feline Leukemia Virus (FeLV) might be causative in Childhood Acute Lymphocytic Leukemia (ALL)

  • Chapter
Adrenal and Endocrine Tumors in Children

Part of the book series: Cancer Treatment and Research ((CTAR,volume 17))

  • 45 Accesses

Abstract

Approximately 40% of childhood cancer is acute leukemia and non-Hodgkin lymphoma [1,2], and nearly 85% of all childhood leukemia in the United States and Europe is acute lymphocytic leukemia (ALL) [2, 3]. ALL is of worldwide distribution, and everywhere it tends to be predominantly a disease of children, with most patients being under ten years of age [3–7]. According to the Third National Cancer Survey [8], the average incidence rate in the United States for ALL in children ages 0–14 years is 2.4 per 100,000. In the United States there is no significant regional variation in the incidence of ALL. Nevertheless, the northern region has the lowest incidence rate (1.8/100,000), whereas the southern and western regions of the country share the highest incidence rate (2.9/100,000). The same survey showed a higher incidence rate (2.7/100,000) in males than in females (2.0/100,000) [8]. Most studies have reported a lower incidence of ALL in American blacks [8–11]. Childhood ALL has a peak incidence at about four years of age in white children [3, 8, 12]. Interestingly, American blacks have a different age of peak incidence, 10–14 years of age [8]. In the United States, it has been documented that the frequency of leukemia is more closely associated with socio-economic status than ethnic group [9]. As the socio-economic status increases, the frequency of ALL rises accordingly [13].

This investigation was supported by grants number CA09128 and CA-25408, awarded by the National Cancer Institute, DHEW

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Castleberry RP: Current trends in childhood acute lymphocytic leukemia and non-Hodgkin’s lymphoma. A1 Jour Med Sci 18 (3): 243–248, 1981.

    CAS  Google Scholar 

  2. Borella L, Sen L, Dow LW, Casper JT: Cell differentiation antigens versus tumor related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers. Hematol Bluttrans 20: 77–85, 1977.

    CAS  Google Scholar 

  3. Altman AJ, Schwartz AD: The Leukemias. Malignant Diseases of Infancy, Childhood and Adolescence (MPCP), Vol 19, 169, 1978.

    Google Scholar 

  4. The Lancet, Epidemiology of leukemia. Lancet 1 (741): 82–3, 1972.

    Google Scholar 

  5. Greaves MF, Janossy G, Roberts M, Rapson NT, Ellis RB, Chessels J, Lister TA, Catovsky D: Membrane phenotyping: Diagnosis, monitoring and classification of acute 4 lymphoid7 leukaemias. Hematol Bluttrans 20: 61–75, 1977.

    CAS  Google Scholar 

  6. Merck Manual, 13th Edition, (eds. Berkow, R., et al.) Merck Sharp and Dohme Res. Lab.; Rahway, NJ, 325–329, 1977.

    Google Scholar 

  7. Essex M: Can feline oncornaviruses cause leukemia in man? Oncology 25: 345–356, 1972.

    Google Scholar 

  8. Third National Cancer Survey: Incidence Data. National Cancer Institute Monograph 41, March, 1975. DHEW Publication No. (NIH) 75–787, USDHEW, Public Health Service, NIH, National Cancer Institute, Bethesda, MD.

    Google Scholar 

  9. MacMahon B, Koller EK: Ethnic differences in the incidence of leukemia. Blood 12: 1–10, 1957.

    PubMed  Google Scholar 

  10. Szklo M, Gordis L, Tonascia J, Kaplan E: The changing survivorship of white and black children with leukemia. Cancer 42: 59–66, 1978.

    PubMed  CAS  Google Scholar 

  11. Olisa EG, Chandra R, Jackson MA, Kennedy J, Williams AO: Malignant tumors in American black and Nigerian children: A comparative study. JNCI 55 (2): 281–284, 1975.

    PubMed  CAS  Google Scholar 

  12. Robbins SL, Cotran RS: Leukemias, Pathologic Basis of Disease 2nd Ed., W.B. Saunders Co., Philadelphia, p. 779, 1979.

    Google Scholar 

  13. Githens JH, Elliot FE, Saunders LH: The relationship of socioeconomic factors to incidence of childhood leukemia. Public Health Reports 80 (7): 573–578, 1965.

    PubMed  CAS  Google Scholar 

  14. Humphrey GB, Blackstock R, Filler J: Cell surface markers in acute lymphoblastic leukemia. Ann Clin Lab Sci 10 (3): 169–80, 1980.

    PubMed  CAS  Google Scholar 

  15. Kumar S, Carr TF, Evans DI, Morris-Jones P, Hann IM: Prognostic significance of cell surface markers in childhood acute lymphoblastic leukemia. Clin Lab Haematol 1:121– 128, 1979.

    Google Scholar 

  16. Aiuti F, Lacava V, Fiorilli M, Ciarla MV: Lymphocyte surface markers in lymphoproliferative disorders. Acta Haematol 50: 275–283, 1973.

    PubMed  CAS  Google Scholar 

  17. Chessells JM, Hardisty RM, Rapson NT, Greaves MF: Acute lymphoblastic leukemia in children: Classification and prognosis. Lancet 2 (8052–53): 1307–9, 1977.

    PubMed  CAS  Google Scholar 

  18. Nadkarni JJ, Nadkarni JS, Advani SH: Surface markers in human lymphoid leukaemias. Ind J Cancer 15: 43–47, 1978.

    CAS  Google Scholar 

  19. Huhn D, Thiel E, Rodt H: Classification of normal and malignant lymphatic cells using acid phosphatase and acid esterase. Klin Wochenschr 58: 65–71, 1980.

    PubMed  CAS  Google Scholar 

  20. Foon KA, Billing RJ, Terasaki PI: Dual B and T markers in acute and chronic lymphocytic leukemia. Blood (55)1: 16–20, 1980.

    Google Scholar 

  21. Rodt H, Netzel B, Thiel E, Jager G, Huber D, Haas R, Gotze D, Thierfelders: Classification of leukemia cells with T and O ALL specific antisera. Hematology and Blood Trans 20: 87–96, 1977.

    CAS  Google Scholar 

  22. Sallan SE, Chess L, Frei E III, O’Brien, Nathan DG, Strominger JL, Schlossman SF: Utility of B-and T-cell-specific antisera in the classification of human leukemias. In: Differentiation of Normal and Neoplastic Hematopoietic Cells (eds. Clarkson B, Marks PA, Till JE ), p. 479–483, Cold Spring Harbor Laboratory, 1978.

    Google Scholar 

  23. Vogler LB, Crist WM, Sarrif AM, Pullen DJ, Bartolucci AA, Falletta JM, Dowell B, Humphrey GB, Blackstock R, van Eys J, Metzgar RS, Cooper MD: An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre–B leukemia. Blood 58 (1): 135–140, 1981.

    PubMed  CAS  Google Scholar 

  24. Reid MM, Craft AW, Walker W: Poor prognosis of T–cell leukemia in children, (letter) Lancet 2 (8047): 1074–1075, 1977.

    PubMed  CAS  Google Scholar 

  25. Sallon SE, Ritz J, Pesando J, Gelber R, O’Brien C, Hitchcock S, Caral F, Schlossman S: Cell surface antigens: Prognostic implications in childhood acute lymphoblastic leukemia. Blood 55: 395–402, 1980.

    Google Scholar 

  26. Dow LW, Borlla L, Sen L, Aur RJ, George SL, Mauer AM, Simone JV: Initial prognostic factors and lymphoblasterythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood 50: 671–682, 1977.

    PubMed  CAS  Google Scholar 

  27. Roper M, Crist W, Ragab A, Pullen J, Humphrey GB, Boyett J, Metzgar R, van Eys J, Nix W, Cooper M: Pre-B cell leukemia differs in its response to therapy. Blood 58 (5): 150A, 1981.

    Google Scholar 

  28. Jaffe S, Berard CW: Lymphoblastic lymphoma; A term rekindled with new precision. Ann Inter Med 89 (3): 415–417, 1978.

    CAS  Google Scholar 

  29. Nathwani BN, Kim H, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38: 964–983, 1976.

    PubMed  CAS  Google Scholar 

  30. Nadler LM, Reinherz EL, Weinstein HJ, D’Orsi CJ, Schlossman SF: Heterogeneity of T–cell lymphoblastic malignancies. Blood 55 (5): 806–810, 1980.

    PubMed  CAS  Google Scholar 

  31. Miller RW: Delayed radiation effects in atomic–bomb survivors. Science. 166: 569–574, 1969.

    PubMed  CAS  Google Scholar 

  32. Polley JR, Borges W, Yamazaki T: Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med 13: 311, 1952.

    Google Scholar 

  33. Potolsky A, Creger WP: Radiation and drug therapies, and leukemia. Annu Rev Med 24: 75–82, 1973.

    PubMed  CAS  Google Scholar 

  34. Lange RD, Moloney WC, Yamazaki T: Leukemia in atomic bomb survivors. Blood 9: 574, 1954.

    PubMed  CAS  Google Scholar 

  35. Moloney WC, Kastenbaum MA: Leukemogenic effects of ionizing radiation on atomic bomb survivors in Hiroshima City. Science 121: 308, 1955.

    PubMed  CAS  Google Scholar 

  36. March HC: Leukemia in radiologists in a 20 year period. AM J M Sc 220: 282, 1950.

    PubMed  CAS  Google Scholar 

  37. Ulrich H: The incidence of leukemia in radiologists. New Engl J Med 234: 45, 1946.

    PubMed  CAS  Google Scholar 

  38. Schwartz AD, Lee H, Baum ES: Leukemia in children with Wilms’ tumor. J Pediatr 87: 374–376, 1975.

    PubMed  CAS  Google Scholar 

  39. Aksoy M: Benzene and leukemia. Lancet 1: 441, 1978.

    PubMed  CAS  Google Scholar 

  40. Vigliana EC, Forni A: Benzene and leukemia. Environ Res 11: 122–127, 1976.

    Google Scholar 

  41. Manning MD, Carroll BE: Some epidemiological aspects of leukemia in children. JNCI 19 (6): 1087–1094, 1957.

    PubMed  CAS  Google Scholar 

  42. Miller RW: Neoplasia and Down’s syndrome. Ann NY Acad Sci 171: 637–644, 1970.

    Google Scholar 

  43. German J, Bloom D, Passarge E: Bloom’s syndrome. Surveillance for cancer in affected families. Clin Genet 12 (3): 162–168, 1977.

    PubMed  CAS  Google Scholar 

  44. O’Gorman Hughes DW: Aplastic anaemia in childhood. III. Constitutional aplastic anaemia and related cytopenias. Med J Aust 1: 519–526, 1974.

    Google Scholar 

  45. Hecht F, McCaw BK, Koler RD: Ataxia–telangiectasia–clonal growth of translocation lym¬phocytes. N Engl J Med 289: 286–291, 1973.

    PubMed  CAS  Google Scholar 

  46. Lilly F, Pincus T: Genetic control of murine viral leukemogenesis. Adv Can Res 17:231– 277, 1973.

    Google Scholar 

  47. Meruelo D, Lieberman M, Ginzton N, Deak B, McDevitt HO: Genetic control of radiation leukemia virus–induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2. J Exp Med 146: 1079–1087, 1977.

    PubMed  CAS  Google Scholar 

  48. Meruelo D: A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation–induced leukemia virus. J Exp Med 149: 898–909, 1979.

    PubMed  CAS  Google Scholar 

  49. Sanderson AR, Mahour GH, Jaffe N and Das L: Incidence of HLA antigens in acute lymphocytic leukemia. Transplantation 16: 672–673, 1973.

    PubMed  CAS  Google Scholar 

  50. Rogentine GN, Trapani RJ, Yankee RA and Henderson ES: HL-A antigens and acute lymphocytic leukemia: The nature of the HL–A2 association. Tissue Antigens 3: 470–476, 1973.

    PubMed  CAS  Google Scholar 

  51. Albert ED, Nisperos B, Thomas ED: HLA antigens and haplotypes in acute leukemia. Leukemia Research 1: 261–269, 1977.

    Google Scholar 

  52. Grumet FC: HLA and disease associations. Transplant Proc 9: 1839–1844, 1977.

    Google Scholar 

  53. Lawler SD, Klouda PT, Smith PG, Till MM and Hardesty RM: Survival and the HLA system in acute lymphoblastic leukemia. Brit Med J 1: 547–548, 1974.

    PubMed  CAS  Google Scholar 

  54. Klouda PT, Lawler SD, Till MM, Hardesty RM: Acute lymphoblastic leukemia and HLA: a prospective study. Tissue Antigens 4: 262–265, 1974.

    PubMed  CAS  Google Scholar 

  55. Davey FR, Lachant NA, Dock NL, Hubbell C, Stockman JA and Henry JB: HLA antigens and childhood acute lymphocytic leukemia. Brit J Haematology 47 (2): 211–220, 1981.

    CAS  Google Scholar 

  56. DeBruyere M, Cornu G, Heremans–Bracke T, Malchaire J, Sokal G: HLA haplotypes and long survival in childhood acute lymphoblastic leukemia treated with transfer factor. Brit J Haematology 44 (2): 243–251, 1980.

    Google Scholar 

  57. Michel K, Hubbel C, Dock NL, Davey FR: Correlation of HLA-Drw3 with childhood acute lymphocytic leukemia. Arch Pathol Lab Med 105: 560, 1981.

    PubMed  CAS  Google Scholar 

  58. Revesz T, Bencz’r M, Gyodi E, Petranyi GG, Schuler D: The association of HLA-DR5 antigen with longer survival in childhood leukemia. Brit J Haematol 48: 508–509, 1981.

    CAS  Google Scholar 

  59. Budowle B, Acton RT, Barger BO, Blackstock R, Crist W, Go RCP, Humphrey GB, Ragab A, Roper M, Vietti T, Dearth J: Properdin factor B and acute lymphocytic leukemia (ALL) Cancer 50: 2369–2371, 1982.

    PubMed  CAS  Google Scholar 

  60. Pike MC, Smith PG: Clustering of Cases of Hodgkin’s Disease and Leukemia. Cancer 34: 1390–1394, 1974.

    PubMed  Google Scholar 

  61. Smith PG, Pike MC, Till MM, Hardisty RM: Epidemiology of Childhood Leukemia in Greater London: A search for evidence of Transmission assuming a possibly long latent period. Br J Cancer 33: 1–8, 1975.

    Google Scholar 

  62. Till MM, Hardisty RM, Pike MC, Doll R: Childhood Leukemia in Greater London: A search for evidence of clustering. Brit Med J 3: 755–758, 1967.

    PubMed  CAS  Google Scholar 

  63. Lock SP, Merrington M: Leukemia in Lewisham (1957–63). Brit Med J 3: 759–760, 1967.

    PubMed  CAS  Google Scholar 

  64. Knox G: Epidemiology of childhood leukemia in Northumberland and Durham. Brit J Prev Soc Med 18: 17–24, 1964.

    CAS  Google Scholar 

  65. Mainwaring D: Epidemiology of acute leukemia of childhood in the Liverpool area. Brit J Prev Soc Med 20: 189–194, 1966.

    CAS  Google Scholar 

  66. Meighan SS, Knox G: Leukemia in childhood: epidemiology in Oregon. Cancer 18: 811–814, 1965.

    PubMed  CAS  Google Scholar 

  67. Heath CW, Hasterlik RJ: Leukemia among children in a suburban community. Amer. J Med 34: 796–812, 1963.

    Google Scholar 

  68. Pike MC, Smith PG: A case–control approach to examine diseases for evidence of contagion, including diseases with long latent periods. Biometrics 30: 263–279, 1974.

    PubMed  CAS  Google Scholar 

  69. Theilen GH: Public health aspects of animal tumor viruses. Theirogenology 6: 331–342, 1976.

    Google Scholar 

  70. Cotter SM: Feline leukemia virus induced disorders in the cat. Vet Clin N Amer 6: 367–378, 1976.

    CAS  Google Scholar 

  71. Hardy WD Jr, Old LJ, Hess PW, Essex M, Cotter S: Horizontal transmission of feline leukaemia virus. Nature 244: 266–269, 1973.

    PubMed  Google Scholar 

  72. Jarrett W, Jarrett O, Mackey L et al.: Horizontal transmission of leukemia virus and leukemia in the cat. JNCI 51: 833–841, 1973.

    PubMed  CAS  Google Scholar 

  73. Piper CE, Abt DA, Ferrer JF et al.: Seroepidemiological evidence of horizontal transmission of bovine C-type virus. Cancer Res 35 (10): 2714–2716, 1975.

    PubMed  CAS  Google Scholar 

  74. Dutcher RM, Larkin EP, Marshak RR: Virus-like particles in cow’s milk from a herd with high incidence of lymphosarcoma. JNCI 33: 1055–1064, 1975.

    Google Scholar 

  75. Kettman R, Portetelle D, Mammerick M, Cleuter Y, DeKegel D, Galou M, Chysdael J, Burney A, Chantrenne H: Bovine leukemia virus: An exogenous RNA oncogenic virus. Proc Natl Acad Sci 73: 1014–1018, 1976.

    Google Scholar 

  76. Ferrer JF, Abt DA, Bhatt DM, Marshak RR: Studies on the relationship between infection with bovine C–type virus, leukemia and persistent lymphocytosis in cattle. Cancer Res 34: 893–900, 1974.

    PubMed  CAS  Google Scholar 

  77. Kawakami TG, Huff SD, Buckley PM, Dungworth DL, Snyder SP, Gilden RV: C–type virus associated with gibbon lymphosarcoma. Nature 225: 170–171, 1972.

    Google Scholar 

  78. Ioachim HL: Prevention of gross virus-induced leukemia in progeny of immunized female rats. Cancer Res 30: 2661–2664, 1970.

    PubMed  CAS  Google Scholar 

  79. Jarrett WFH, Crawford E, Martin WB, Davie F: A Virus-like Particle associated with Leukemia (Lymphosarcoma). Nature 202: 567–569, 1964.

    PubMed  CAS  Google Scholar 

  80. Allen DW, Cole P: Viruses and human cancer. N Engl J Med 286: 70–82, 1972.

    PubMed  CAS  Google Scholar 

  81. Francis DP, Essex M: Leukemia and lymphoma: Infrequent manifestations of common viral infections? A review. J Infect Dis 138 (6): 916–923, 1978.

    PubMed  CAS  Google Scholar 

  82. Baxt W et al.: Human leukemic cells containing reverse transcriptase associated with a high molecular weight virus–related RNA. Nature 240: 72, 1972.

    CAS  Google Scholar 

  83. Holland JF: The acute leukemias: In: Cecil Text of Med. 5th Ed. Vol. II, p. 1813, (eds., Beeson PB, McDermott W, Wyngaarden JB ). WB Saunders Co., Philadelphia, 1979.

    Google Scholar 

  84. Gallo RC, Yong DS, Ting RC: RNA–dependent DNA polymerase of human acute leukemic cells. Nature 228: 927, 1970.

    PubMed  CAS  Google Scholar 

  85. Ioachim HL, Sabbath M, Andersson B, Keller S: Viral and chemical leukemia in the rat: Comparative study. JNCI 47 (1): 161–168, 1971.

    PubMed  CAS  Google Scholar 

  86. Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC: Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in the sera of leukemia patients in Japan, Proc Natl Acad Sci USA 79: 1653–1657, 1982.

    PubMed  CAS  Google Scholar 

  87. Catovsky D, Rose M, Goolden AWG, White JM, Bourikas G et al.: Adult T–cell lymphoma-Leukaemia in Blacks from the West Indies. Lancet 8273: 643, 1982.

    Google Scholar 

  88. Hinuma Y, Nagata K, Hanaoka M, et al.: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78: 6476–6480, 1981.

    PubMed  CAS  Google Scholar 

  89. Gallo RC, Blattner WA, Reitz MS Jr, Ito Y: HTLV: The Virus of adult T-cell leukaemia in Japan and Elsewhere. Lancet 8273: 683, 1982.

    Google Scholar 

  90. Mier JW, Gallo RC: Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA 77: 6134–6138, 1980.

    PubMed  CAS  Google Scholar 

  91. Essex M: Adult T-cell leukemialymphoma: Role of a human retrovirus. JNCI 69(4): 981– 985, 1982.

    Google Scholar 

  92. Gallo RC, Wong–Staal F: Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood 60 (3): 545–557, 1982.

    PubMed  CAS  Google Scholar 

  93. Donham KJ, Berg JW, Sawin RS: Epidemiologic relationship of bovine population and human leukemia in Iowa. Amer J Epidemiol 112 (1): 80–92, 1980.

    CAS  Google Scholar 

  94. Gupta P, Ferrer JF: Expression of Bovine Leukemia Virus Genome Is Blocked by a Non-immunoglobulin Protein in Plasma from infected cattle. Science 215: 405–407, 1982.

    PubMed  CAS  Google Scholar 

  95. Ferrer JF, Kenyon SJ, Gupta P: Milk of Dairy Cows Frequently contains a Leukemogenic Virus. Science 213: 1014–1016, 1981.

    PubMed  CAS  Google Scholar 

  96. Reif JS: Pet associated zoonoses. In: Current Vet Therapy VI (eds. Kirk RW et al.), p. 1433, WB Saunders Co., Philadelphia, 1977.

    Google Scholar 

  97. Levy SB: Cat leukemia: A threat to man? N Engl J Med 290 (9): 513–14, 1974.

    PubMed  CAS  Google Scholar 

  98. Gilmore CE, Holzworth J: Naturally occurring feline leukemia: Clinical, pathologic, and differential diagnostic features. JAVMA 158: 1013–1025, 1971.

    PubMed  Google Scholar 

  99. Jarrett O, Laird HM, Hay D, Jarrett WFH: Feline leukemia. J Small Anim Pract 10: 599–603, 1969.

    PubMed  CAS  Google Scholar 

  100. Benveniste RE, Todaro GJ: Evolution of type C viral genes: Origin of feline leukemia virus. Science 190: 886–888, 1975.

    PubMed  CAS  Google Scholar 

  101. Hardy WD Jr., Hess PW, MacEwen EG, McClelland AJ, Zuckerman EE, Essex M, Cotter SM, Jarrett O: Biology of Feline leukemia virus in the natural environment. Cancer Res 36: 582–588, 1976.

    PubMed  Google Scholar 

  102. Hardy WD Jr: Immunopathology of Lymphoreticular Neoplasms (eds. Twomey JJ and Good RA), 129–180. Plenum, New York, 1978.

    Google Scholar 

  103. Cotter SM: Update on Feline Leukemia. In: Proceedings: American Animal Hospital Association 46th Annual Meeting, 119–121, 1979.

    Google Scholar 

  104. Francis DP, Essex M, Hardy WD, Jr.: Excretion of feline leukaemia virus by naturally infected pet cats. Nature 269: 252–254, 1977.

    PubMed  CAS  Google Scholar 

  105. Gardner MB, Rongey RW, Johnson EY, DeJournett R, Huebner JR: C–type tumor virus particles in salivary tissue of domestic cats. JNCI 47: 561–565, 1971.

    PubMed  CAS  Google Scholar 

  106. Hardy WD, Jr., Geering G, Old LJ, deHarven E, Brodey RS, McDonough S: Feline leukemia virus: occurrence of viral antigens in the tissues of cats with lymphosarcoma and other diseases. Science 166: 1019–1021, 1969.

    PubMed  Google Scholar 

  107. Hoover EA, Olsen RG, Mathes L et al.: Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow and saliva of cats. Cancer Res 37: 3707–3710, 1977.

    PubMed  CAS  Google Scholar 

  108. Ladiges WC, DiGiacomo RF, Wardrop KJ, Hardy WD, Jr.: Prevalence and sequelae of feline leukemia virus infection in laboratory cats. JAVMA 179 (11): 1206–1207, 1981.

    PubMed  CAS  Google Scholar 

  109. Hardy WD, Jr: The Virology, Immunology and Epidemiology of the Feline Leukemia Virus. In: Feline Leukemia Virus, (eds. Hardy WD, Jr, Essex M, McClellan AJ ), 33–78. Elsevier North Holland, Inc. 1980.

    Google Scholar 

  110. Holzworth J: Leukemia and related neoplasms of the cat. I. Lymphoid neoplasms. JAV¬MA 136: 47–69, 1960.

    CAS  Google Scholar 

  111. Neilsen SW: Neoplastic diseases: In: Catcott: Feline Medicine and Surgery, American Veterinary Publication, Wheaton, 1964.

    Google Scholar 

  112. Laird HM, Jarrett O, Crighton GW and Jarrett WFH: An electron microscopic study of virus particles in spontaneous leukemia in the cat. JNCI 41: 867–878, 1968.

    PubMed  CAS  Google Scholar 

  113. Jarrett O, Laird HM, Hay D: Growth of feline leukemia virus in human cells. Nature 224: 1208–1209, 1969.

    PubMed  CAS  Google Scholar 

  114. Hardy WD, Jr., Suckerman EE, MacEwen EG, et al.: A feline leukemia and sarcoma virus induced tumor specific antigen. Nature 270: 249–251, 1977.

    PubMed  Google Scholar 

  115. Essex M, Cotter SM, Carpenter JL: Feline virus–induced tumors and the immune response: Recent developments. Am J Vet Res 34: 809–812, 1973.

    PubMed  CAS  Google Scholar 

  116. Hoover EA, Olsen RG, Hardy WD, Jr., Schaller JP, Mathes LE: Feline leukemia virus infection: Age-related variation in response of cats to experimental infection. JNCI 57: 365–369, 1976.

    PubMed  CAS  Google Scholar 

  117. Essex M, Cotter SM, Carpenter JL, Hardy WD, Jr., Hess P, Jarrett W, Schaller JP, Yohn DS: Feline oncornavirus-associated cell membrane antigen II. Antibody titers in healthy cats from household and laboratory colony environments. JNCI. 54: 631, 1975.

    PubMed  CAS  Google Scholar 

  118. Jarrett O: Growth of feline leukemia virus in human, canine, and porcine cells. Proc. 4th Int Symp on Comparative Leukemia Research, Cherry Hill, NJ, 1969.

    Google Scholar 

  119. Azocar J, Essex M: Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus. JNCI 63: 1179–1184, 1979.

    PubMed  CAS  Google Scholar 

  120. Olsen RG, Mathes LE, Yohn DS: In Comparative Leukemia Research 1973, (eds. Ito Y, Dutcher RM ), Krager/Basel, 419–429, 1975.

    Google Scholar 

  121. Caldwell GC, Baumgartener L, Carter C, Cotter S, Currier R, Essex M, Hardy W, Olson C, Olsen R: In: Comparative Leukemia Research 1975, (eds. Clemmesen J, Yohn DS ), Karger/Basel, 238–241, 1976.

    Google Scholar 

  122. Sordillo PP, Markovich RP, Hardy WD Jr: Search for evidence of feline leukemia virus infection in Humans with leukemias, lymphomas, or soft tissue sarcomas. JNCI 69(2): 333– 337, 1982.

    Google Scholar 

  123. Francis DP, Essex M, Cotter SM, Gutensohn N, Jakowski R, Hardy WD Jr: Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Lett 12: 37–42, 1981.

    PubMed  CAS  Google Scholar 

  124. Hardy WD Jr, McClelland AJ, Zuckerman EE, et al.: Development of virus nonproducer lymphosarcomas in pet cats exposed to FeLV. Nature 288: 90–92, 1980.

    PubMed  Google Scholar 

  125. Sliski AH, Essex M, Meyer C, Todaro GJ: Feline oncornavirus associated cell membrane antigen (FOCMA): Expression on feline sarcoma virus–transformed nonproducer mink cells. Science 196: 1336–1339, 1977.

    PubMed  CAS  Google Scholar 

  126. Bross ID, Gibson R: Cats and childhood leukemia. J Med (BASEL) 1: 180–187, 1970.

    CAS  Google Scholar 

  127. Penrose M: Cat Leukaemia. Brit Med J 1: 755, 1970.

    CAS  Google Scholar 

  128. Bross ID, Bertell R, Gibson R: Pets and adult leukemia. AJPH 62 (11): 1520–31, 1972.

    CAS  Google Scholar 

  129. Fasal E, Jackson EW, Klauber MR: Mortality in California Veterinarians. J Chron Dis 19: 293–306, 1966.

    PubMed  CAS  Google Scholar 

  130. Botts RP, Edlavitch S, Payne G: Mortality of Missouri Veterinarians. JAVMA 149 (5): 499–504, 1966.

    PubMed  CAS  Google Scholar 

  131. Schnurrenberger PR, Martin RJ, Walker JF: Mortality in Illinois Veterinarians. JAVMA, 170 (10): 1071–1075, 1977.

    Google Scholar 

  132. Blair A, Hayes HM Jr: Cancer and other causes of death among US veterinarians, 1966– 1977. Int J Cancer 25: 181–185, 1980.

    PubMed  CAS  Google Scholar 

  133. Guthensohn N, Francis DP, Hardy WD, Jr., Essex M: In: Viruses in Naturally Occurring Cancer (eds. Essex M, Todaro G, ZurHausen H ), Cold Spring Harbor Lab, New York, 1980.

    Google Scholar 

  134. Schneider R: The natural history of malignant lymphoma and sarcoma in cats and their associations with cancer in man and dog. JAVMA 157 (11): 1753–1758, 1970.

    PubMed  CAS  Google Scholar 

  135. Hanes B, Gardner MB, Loosli CG, Heidbreder G, Kogan B, Marylander H, Huebner RJ: Pet association with selected human cancers: A household questionnaire survey. JNCI 45 (6): 1155–1162, 1970.

    PubMed  CAS  Google Scholar 

  136. Safety Standards for Research Involving Oncogenic Viruses, Department of Health, Edu¬cation and Welfare publication (NIH) 75–790, National Cancer Institute, 1974.

    Google Scholar 

  137. Essex M, Hardy WD Jr., Cotter SM, et al.: Naturally occurring resistant feline oncornavirus infections in the absence of disease. Infection and Immunity 11: 470–475, 1975.

    PubMed  CAS  Google Scholar 

  138. Hardy WD Jr: Immunodiffusion studies of feline leukemia and sarcoma. JAVMA 158: 1060, 1971.

    PubMed  Google Scholar 

  139. Maruyama K, Dmochowski L, Richard CG: A search for antural antibody against feline and murine leukemia antigen by mixed hemadsorption test. JAVMA 158: 1076, 1971.

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Malone, G.E., Roseman, J., Crist, W.M., Acton, R.T. (1983). A Review of Evidence that the Feline Leukemia Virus (FeLV) might be causative in Childhood Acute Lymphocytic Leukemia (ALL). In: Humphrey, G.B., Grindey, G.B., Dehner, L.P., Acton, R.T., Pysher, T.J. (eds) Adrenal and Endocrine Tumors in Children. Cancer Treatment and Research, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3891-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3891-8_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3893-2

  • Online ISBN: 978-1-4613-3891-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics